课题基金 / 基金详情

Computer Directed Photodynamic Therapy of Prostate Ca

Computer Directed Photodynamic Therapy of Prostate Ca
计算机引导前列腺钙光动力治疗
批准号:
6845684
负责人:
JERZY JANKUN
金额:
$28.71万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-02 至 2007-02-28

项目摘要

项目成果

JERZY JANKUN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(摘自申请人摘要):提案的目的
英文摘要
DESCRIPTION (Verbatim from Applicant's Abstract): The objective of the proposal is to provide a critical body of knowledge with the ultimate goal of transferring photodynamic therapy (PDT) to the clinical arena for the treatment of prostate cancer. The widespread use of PSA test as an adjunct to digital rectal examination has led to an increase in the diagnosis of prostate cancer in its early stages. Treatment of organ confined prostatic cancer includes radical prostatectomy, radiotherapy, brachytherapy and cryosurgical ablation. Results from all these are favorable at least in terms of short outcomes. Still, with Tic disease, 30 percent of patients will have biochemical failure within 5 years of treatment. Clearly novel methods of prostate cancer treatment are needed. We want to utilize PDT as a novel approach to the treatment of prostatic cancer. PDT for prostate cancer depends on the sequestration of a PDT drug within the glandular tissue of the prostate. The photosensitizer is subsequently activated by high-energy light producing cytotoxic substances, which in turn destroy cancerous tissue. Since prostate cancer is a multi-focal disease, PDT must ablate the prostate completely. Complete ablation will depend on quantification of tissue sensitivity to a photosensitizer, precise placement of light sources in the prostate and delivery of a therapeutic light dose to the entire gland. The prostate is irregular in shape, so transurethral light delivery cannot be used for the treatment of the majority of prostate cancers. Additionally, most cancers are located in the peripheral zone of the prostate, an area unlikely to be reached by transurethrally launched light. Sources of light and their spatial distribution must be tailored to each patient. More uniform light distribution can be achieved by interstitial light irradiation. In this case, the light is delivered by diffusers placed within the substance of the prostate parallel to the urethra at a distance optimized to deliver adequate levels of light and to create the desired photodynamic effect. To achieve uniform light distribution throughout the prostate we are developing a computer program that can determine treatment effects by calculating the distribution of light energy depending on the number of light sources placed in the prostate, their position in the gland, the dimension of the prostate, and the tissue attenuation coefficient.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3892/ijmm.20.5.683
发表时间: 2007-11
期刊: International journal of molecular medicine
影响因子: 5.4
作者: [J. Jankun;Ansari M. Aleem;S. Selman;E. Skrzypczak‐Jankun;W. Lysiak-Szydlowska;Nicholas Grafos;H. J. Fryer;R. Greenfield]
通讯作者: J. Jankun;Ansari M. Aleem;S. Selman;E. Skrzypczak‐Jankun;W. Lysiak-Szydlowska;Nicholas Grafos;H. J. Fryer;R. Greenfield
Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells.
纤溶酶原激活剂抑制剂 1 型突变体调节人脐血管和肺血管内皮细胞的血管生成。
DOI: --
发表时间: 2004
期刊: Oncology reports.
影响因子: --
作者: [Chorostowska-Wynimko,Joanna, Swiercz,Rafal, Skrzypczak-Jankun,Ewa, Selman,StevenH, Jankun,Jerzy]
通讯作者: Jankun,Jerzy
Plasminogen activator inhibitor type-1 controls the process of the in vitro sprout formation.
1 型纤溶酶原激活剂抑制剂控制体外芽形成的过程。
DOI: --
发表时间: 2004
期刊: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
影响因子: --
作者: [Chorostowska-Wynimko,J, Skrzypczak-Jankun,E, Jankun,J]
通讯作者: Jankun,J
DOI: 10.3892/ijmm.17.3.437
发表时间: 2006-03
期刊: International journal of molecular medicine
影响因子: 5.4
作者: [J. Jankun;Z. Specht;Marian Szkudlarek;R. Greenfield;B. Gaikwad;L. Trifonov;J. Vaugeois;Ansari M. Aleem;V. Basrur;S. Selman;M. Zavodszky;E. Skrzypczak‐Jankun]
通讯作者: J. Jankun;Z. Specht;Marian Szkudlarek;R. Greenfield;B. Gaikwad;L. Trifonov;J. Vaugeois;Ansari M. Aleem;V. Basrur;S. Selman;M. Zavodszky;E. Skrzypczak‐Jankun
共 12 条
    Genetically Engineered PAI1 for Anti-cancer Therapy
    Genetically Engineered PAI1 for Anti-cancer Therapy
    Computer Directed Photodynamic Therapy of Prostate Ca
    Computer Directed Photodynamic Therapy of Prostate Ca
    海外基金